Status:
UNKNOWN
Expression of STEAP-1 and p40 in Prostatic Carcinoma and Its Mimickers
Lead Sponsor:
Sohag University
Conditions:
Prostatic Carcinoma
Eligibility:
MALE
Brief Summary
Prostatic carcinoma is the second most common cancer in men with high incidence of morbidity and mortality. It is a common health problem. Most cases occur at the age of 50 years, reaching its peak at...
Eligibility Criteria
Inclusion
- Trans-rectal ultrasound guided biopsy (TRUS) procedure, transurethral resection prostatectomy (TURP) and radical prostatectomy.
- Prostatic adenocarcinoma and prostatic lesions that mimic prostatic adenocarcinoma
Exclusion
- Patients with recurrence of the primary tumor.
- Patients with a history of preoperative chemotherapy and/or radiotherapy.
- Insufficient or tiny tissue biopsies
Key Trial Info
Start Date :
December 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05428319
Start Date
December 1 2022
End Date
December 1 2024
Last Update
September 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aliaa Bakr Ahmed
Sohag, Egypt, 201